Menstural function preservation treatment of a primary vaginal clear cell carcinoma with ovarian transposition and vaginal brachytherapy.
Brachytherapy
Clear cell carcinoma
Preservation of menstrual function
Vaginal cancer
Journal
Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
20
01
2021
revised:
22
03
2021
accepted:
27
03
2021
entrez:
29
4
2021
pubmed:
30
4
2021
medline:
30
4
2021
Statut:
epublish
Résumé
Early stage vaginal carcinomas are typically treated with radical surgical procedures or radiation therapy. Both modalities impair the reproductive ability of the patients. We hereby report a case of menstrual function preservation in a 24-year-old patient with an early-stage primary vaginal clear cell carcinoma. We treated the patient with intravaginal brachytherapy after appropriate laparoscopic surgical staging and separate transposition of the ovaries and tubes. The patient is now 6 years without any evidence of disease. She reports minor. complaints during sexual intercourse, while her menstruation and hormonic profile are normal.
Identifiants
pubmed: 33912644
doi: 10.1016/j.gore.2021.100764
pii: S2352-5789(21)00069-2
pmc: PMC8063755
doi:
Types de publication
Case Reports
Langues
eng
Pagination
100764Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Medicine (Baltimore). 2018 Dec;97(49):e13470
pubmed: 30544435
Cancer. 1997 Jun 1;79(11):2229-36
pubmed: 9179071
Differentiation. 2011 Oct;82(3):117-26
pubmed: 21612855
Best Pract Res Clin Obstet Gynaecol. 2004 Apr;18(2):349-71
pubmed: 15157647
Gynecol Oncol. 2013 Oct;131(1):77-82
pubmed: 23769758
J Ovarian Res. 2014 Jun 25;7:69
pubmed: 24995040
Dev Biol. 2013 Sep 1;381(1):5-16
pubmed: 23830984
Obstet Gynecol. 1982 Nov;60(5):546-51
pubmed: 6890656
Am J Obstet Gynecol. 1999 Dec;181(6):1576-8; discussion 1579
pubmed: 10601947
Mol Endocrinol. 2016 Jul;30(7):783-95
pubmed: 27164167
Development. 2004 Apr;131(7):1639-49
pubmed: 14998922
World J Surg Oncol. 2019 Dec 4;17(1):206
pubmed: 31801560
Clin Oncol (R Coll Radiol). 1992 May;4(3):192-3
pubmed: 1586639
Int J Gynecol Cancer. 2012 Oct;22(8):1378-82
pubmed: 22932263
J Obstet Gynaecol Res. 2010 Jun;36(3):681-5
pubmed: 20598057
Oncotarget. 2017 Jul 11;8(28):46580-46592
pubmed: 28418849
Patholog Res Int. 2012;2012:674748
pubmed: 23213623